🇺🇸 FDA
Patent

US 7348324

Cyclic amine compounds as CCR5 antagonists

granted A61PA61P31/18A61P43/00

Quick answer

US patent 7348324 (Cyclic amine compounds as CCR5 antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61P, A61P31/18, A61P43/00